Capnat (Capecitabine) — Patient Information (Australia)

Capnat contains capecitabine, an anti-cancer medicine used to treat several types of cancer. This page explains how capecitabine works, how it is used, important safety information, and practical tips for taking it. Always follow the directions provided by your treating team.

1. Basic product information

• Medicine name: Capnat (capecitabine)
• Active ingredient: Capecitabine
• Medicinal class: Antimetabolite (fluoropyrimidine)
• How it is taken: By mouth (tablets)
• Commonly used for: Breast, colorectal, and other cancers (as determined by your clinician)
• Branding: Different brands may exist; your doctor/pharmacist will specify which to use

Note: This information is intended to help you understand the medicine. It does not replace personalised advice from your healthcare professional.

2. How Capnat (capecitabine) works (mechanism of action)

Capecitabine is designed to become active in the body and interfere with DNA and cell growth:

• Capecitabine is converted into 5-fluorouracil (5-FU) through a series of steps.
• Some enzymes involved in this conversion are found at higher levels in tumour tissue.
• The active drug disrupts how cells make and repair DNA.
• This slows or stops the growth of rapidly dividing cancer cells.

Because cancer cells often divide more quickly than healthy cells, treatment aims to target tumour growth while maintaining tolerable effects on normal tissues.

3. Pharmacokinetics (how the body handles it)

Pharmacokinetics describes what happens to a medicine in the body—absorption, conversion to active forms, distribution, and elimination.

• Absorption: Capecitabine is absorbed after oral dosing.
• Conversion: It is metabolised in the body to 5-FU, and then further processed.
• Peak activity: The timing of active metabolites typically occurs after oral dosing and varies between individuals.
• Metabolism: It is broken down mainly in the liver and other tissues.
• Excretion: Metabolites are eliminated primarily via the kidneys (urine).

Kidney function matters: People with reduced kidney function may have higher exposure to capecitabine or its metabolites and may need dose adjustments. Your clinician may request blood tests before and during treatment.

4. Typical use (what it’s used for)

Capecitabine is used for several cancer types, often:

• Breast cancer: Including adjuvant (after surgery) and metastatic disease, depending on the individual plan.
• Colorectal cancer: Including metastatic colorectal cancer and some stages in combination strategies.
• Other approved settings: Your clinician will specify when capecitabine is appropriate based on cancer type, stage, and overall treatment goals.

Combination therapy: Capecitabine is sometimes used with other anti-cancer medicines or treatments. The exact regimen (schedule, dose, and duration) depends on your cancer and treatment plan.

5. Indications (conditions where Capnat may be recommended)

Indications vary depending on local approvals, clinical guidelines, and your specific medical circumstances. Commonly, capecitabine is used when:

• Oral fluoropyrimidine therapy is an appropriate option
• A treatment plan includes capecitabine as part of therapy for certain breast and colorectal cancers
• Combination regimens are considered to improve outcomes in particular settings

Your treating team will match the medicine choice and schedule to your diagnosis and overall health.

6. Dosing — how it is usually taken

Dose is individual and depends on factors such as body size, kidney function, age, and how well you tolerate therapy. Commonly, capecitabine dosing is calculated using body surface area (BSA) (a formula based on height and weight).

Common schedule pattern

A frequently used regimen is taken in cycles, for example:

• Twice daily dosing
• Days of treatment followed by a rest period within each cycle

Important: The exact number of days on treatment and the length of the rest period varies by regimen. Follow your specific cycle instructions from your healthcare provider.

How to take your tablets

• Take tablets by mouth.
• Swallow with water.
• Do not crush, split, or chew unless your pharmacist specifically advises otherwise.
• If a dose is missed, follow the guidance provided by your treating team or pharmacist. (Do not double up.)

If you vomit after taking a dose: Contact your healthcare provider or pharmacist for advice on whether to take another dose. Do not automatically repeat doses without guidance.

7. Timing and meal guidance (food interactions)

Capecitabine has specific instructions regarding meals:

• Take your doses within 30 minutes after food (a meal or snack).
• If you take it on an empty stomach, absorption may be affected and side effects may become harder to manage.

Practical meal approach:

• Plan meals at the same times each day when possible.
• Keep a consistent routine so you don’t accidentally delay or skip the “after food” timing.

8. Alcohol interactions and considerations

There is no single universal rule that capecitabine must never be taken with alcohol. However, alcohol may affect:

• Stomach and bowel effects: Alcohol can worsen nausea or diarrhoea.
• Liver stress: Capecitabine metabolism involves the liver; alcohol may add extra strain.
• Hydration status: Alcohol can contribute to dehydration, which is important if you have diarrhoea or poor intake.

Safer approach: Limit alcohol as advised by your clinician and avoid alcohol if you’re experiencing significant nausea, diarrhoea, mouth ulcers, or poor appetite. If you’re unsure, ask your pharmacist or oncology team.

9. Medicine interactions (including common medicines)

Capecitabine can interact with other medicines. Some interactions increase the risk of side effects, while others may reduce effectiveness or affect blood levels.

Medicines that commonly require extra caution

• Warfarin and other anticoagulants (blood thinners): may increase bleeding risk in some patients. If you take anticoagulants, your clotting tests require close monitoring.
• Phenytoin (for seizures): can have altered levels when used with chemotherapy agents.
• Folinic acid (leucovorin): may be used in some regimens and can affect the activity of fluoropyrimidines.
• Allopurinol: may change how drugs interact and could affect toxicity risk.
• Other cancer medicines or radiotherapy: combination can affect side effect profiles.
• Medicines affecting the immune system: may require special planning.

Herbal and supplement interactions

Herbal products and supplements can also interact with cancer medicines. It’s important to tell your pharmacist about:

• St John’s wort
• High-dose vitamins or supplements
• Any “natural” remedies used during treatment

General interaction tips

• Keep a written list of all medicines, including over-the-counter products.
• Ask your pharmacist before starting new medicines, including cold/flu products.
• Be especially careful with products that affect blood thinning, liver function, or gut function.

10. Safety profile — what to watch for

Like all medicines, capecitabine can cause side effects. Not everyone experiences them, and severity varies. Your treatment team may adjust doses or pause therapy to manage side effects.

Common side effects

• Hand-foot syndrome (HFS): redness, swelling, pain, or peeling of the palms and soles
• Diarrhoea
• Nausea and sometimes vomiting
• Mouth ulcers or soreness
• Fatigue
• Loss of appetite
• Low blood counts (may lead to increased infection risk, bruising, or anaemia)
• Abdominal discomfort

Less common but serious side effects

Seek urgent medical advice if you experience:

• Severe diarrhoea, especially with dehydration or weakness
• Signs of infection: fever, chills, or feeling very unwell
• Bleeding or unusual bruising
• Severe allergic-type reactions: rash, swelling of face/lips, breathing difficulty
• Severe weakness, dizziness, or fainting
• Chest pain or significant breathing difficulties

When to contact your healthcare provider promptly

• Any signs of hand-foot syndrome (early changes should be reported)
• Mouth sores that prevent eating/drinking
• Persistent nausea/vomiting
• Symptoms of dehydration (dry mouth, reduced urine, extreme thirst)

11. Practical use tips (to help you take Capnat safely)

Before you start

• Discuss your kidney function and any history of severe side effects from fluoropyrimidines.
• Arrange blood tests as planned (full blood count and kidney/liver function may be checked).
• Ask about anti-nausea medicines or other supportive treatments that may be used with your regimen.

During treatment

• Meal timing: take doses within 30 minutes after food.
• Hydration: aim for good fluid intake, particularly if you develop diarrhoea.
• Skin care for hand-foot syndrome:
  • Use moisturisers regularly (avoid very hot water).
  • Protect hands and feet from friction and pressure (comfortable footwear, gloves for chores).
  • Avoid activities that increase rubbing or heat on palms/soles.
• Mouth care: keep your mouth clean; report soreness early. Ask about mouthwash options.
• Infection prevention: report fever immediately; avoid close contact with people who are sick when possible.
• Blood count awareness: bruising, bleeding, or unusual fatigue should be reported.

Handling chemotherapy tablets safely at home

Capecitabine is cytotoxic (chemotherapy). Your pharmacist may provide handling advice. Generally:

• Wear gloves if you need to handle broken tablets (follow local instructions).
• Avoid crushing or unnecessary handling.
• Wash hands after handling.
• Keep tablets in the original packaging, out of reach of children.

If you’re unsure about safe handling for your specific tablets and packaging, ask your pharmacist.

12. Dose adjustments and special populations

Your clinician may adjust capecitabine based on:

• Kidney function: dose adjustments may be needed.
• Age and overall health
• Prior treatment history
• Toxicity severity (for example, recurrent severe diarrhoea or hand-foot syndrome)

Do not change your dose without medical advice.

13. Alternatives to Capnat (capecitabine)

Alternative options depend on cancer type, stage, previous treatments, and your overall health. Potential alternatives may include:

• Other oral or intravenous fluoropyrimidines (for example, 5-fluorouracil-based regimens in some protocols)
• Different chemotherapy agents used alone or in combinations
• Targeted therapies or immunotherapies for certain molecular profiles
• Radiotherapy or surgery in appropriate settings

Your oncology team can discuss which alternatives (if any) are suitable for your diagnosis and treatment goals.

14. Market and legal context for Australia (patient-friendly overview)

In Australia, medicines are regulated through the Therapeutic Goods Administration (TGA) and supplied under the national framework for medicines safety and quality.

• Availability: Capecitabine is generally supplied via pharmacy channels for eligible patients.
• Quality assurance: Australian supply chains follow standards for manufacturing, storage, and distribution.
• Therapeutic monitoring: Because capecitabine can cause significant side effects, treatment is typically managed with appropriate clinical review and monitoring.

Always rely on reputable pharmacy supply and advice relevant to Australia’s requirements.

15. Recent guidance and monitoring (general overview)

While individual protocols vary by cancer type and regimen, modern cancer care commonly emphasises:

• Early recognition and prompt management of side effects (especially diarrhoea and hand-foot syndrome)
• Regular blood tests to monitor blood counts and kidney function
• Informed dose modifications to maintain safety and treatment continuity
• Clear symptom reporting so clinicians can intervene quickly

Ask your treating team about the specific monitoring schedule for your regimen.

16. Delivery and availability (online pharmacy notes)

Availability and delivery options can vary depending on stock levels, product strength, and packaging. In general:

• Dispatch timing: depends on prescription verification, stock, and pharmacy workflow.
• Packaging: medicines are typically packaged securely to protect tablets and comply with handling requirements.
• Storage: keep tablets according to the label instructions (usually at room temperature away from moisture and direct heat).
• Temperature and transit: follow the label requirements; most tablet formulations are not temperature-sensitive unless specifically labelled.

Tip: If you live far from major centres, ask about delivery timeframes and tracking.

17. Storage and disposal

• Store tablets according to the label.
• Keep out of sight and reach of children.
• Do not use beyond the expiry date printed on the carton/blister.
• Ask your pharmacist about disposal options for unused tablets.

18. FAQ — Capnat (capecitabine)

How soon will I notice effects?

Some people feel changes during the first cycle, but response to chemotherapy is usually assessed over weeks to months using clinical review and imaging or tumour markers as appropriate for your cancer.

What is hand-foot syndrome, and how can I reduce risk?

Hand-foot syndrome (HFS) can cause redness, swelling, pain, tingling, or peeling of the palms and soles. To reduce risk, protect hands and feet from heat and friction, moisturise regularly, avoid hot water, and report symptoms early to your clinician.

Can I take Capnat with food?

Yes. In most regimens, capecitabine should be taken within 30 minutes after food (meal or snack). Try to keep the timing consistent.

What should I do if I miss a dose?

Follow the instructions provided by your treating team or pharmacist. In general, you should not double up to make up for a missed dose unless specifically told to do so.

Are there foods I should avoid?

There are no strict universal food bans, but maintaining consistent meal timing is important. If you develop nausea or diarrhoea, your clinician may recommend diet adjustments. Stay hydrated if diarrhoea occurs.

Can I drive or operate machinery?

Capecitabine may cause fatigue or dizziness in some people. If you feel unwell, tired, or light-headed, avoid driving or operating machinery until you feel safe.

What blood tests will I need?

Clinicians commonly monitor full blood counts and kidney function, and sometimes liver tests, before and during treatment. Your schedule depends on your regimen and your individual risk factors.

Is it safe to receive vaccinations during treatment?

Vaccination advice depends on your treatment intensity and your immune status. Ask your oncology team or pharmacist about which vaccines are safe for you.

Can I take over-the-counter pain relief?

Many people do use pain relief during cancer treatment, but the safest option depends on your overall health and other medicines (for example, if you take anticoagulants). Ask your pharmacist for guidance on what is suitable for you.

Does capecitabine affect fertility?

Some chemotherapy agents can affect fertility. If fertility preservation is a consideration, discuss options with your clinician before starting treatment.

When should I seek urgent help?

Seek urgent medical help if you have fever or signs of serious infection, severe diarrhoea, signs of dehydration, severe allergic reactions, uncontrolled bleeding, or severe shortness of breath/chest pain.

19. Summary

Capnat (capecitabine) is an oral chemotherapy medicine used in certain cancers. It works by interfering with DNA processes after converting to an active form in the body. It is typically taken in scheduled cycles, and it is important to take it within 30 minutes after food. Safety monitoring—especially for diarrhoea, hand-foot syndrome, blood count changes, and kidney function—is essential. If you have questions about interactions with other medicines or how to manage side effects, speak to your pharmacist or treating team.